Monopar Therapeutics Inc

NASDAQ:MNPR   9:35:36 AM EDT
4.03
+0.23 (+6.05%)
Earnings Announcements

Monopar Q3 Loss Per Share $0.20

Published: 11/12/2021 14:46 GMT
Monopar Therapeutics Inc (MNPR) - Monopar Therapeutics Reports Third Quarter 2021 Financial Results and Recent Clinical Developments.
Q3 Loss per Share $0.20.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.29

More details on our Analysts Page.